Chris Drakeley

Chris Drakeley is a Professor of Infection and Immunity at the London School of Hygiene & Tropical Medicine (LSHTM), specializing in malaria epidemiology and transmission control. He leads major global initiatives funded by the Bill & Melinda Gates Foundation and others, focusing on malaria elimination strategies, drug efficacy, and surveillance systems in Sub-Saharan Africa, Southeast Asia, and Latin America. His work spans zoonotic malaria (P. knowlesi), serological assay development for P. vivax, and evaluating intervention impacts via randomized controlled trials.

Research Interests:

• Malaria transmission dynamics
• Antimalarial drug efficacy
• Serosurveillance and diagnostics
• Zoonotic pathogens
• Climate change impacts on infectious diseases

Grants & Leadership: Current grants include £3.5M for PvSTATEM serology trials and £4M for vivax diagnostics. He advises WHO’s Global Malaria Programme and chairs the Malaria Journal editorial board. Recent achievements include pioneering work on Plasmodium vivax radical cure modeling and co-authoring over 600 peer-reviewed publications.

Awards: Distinguished International Fellow (American Society of Tropical Medicine and Hygiene, 2024–2034).

Global Engagement: Active in 12 countries including Uganda, The Gambia, and Malaysia. Leads LSHTM’s collaboration with institutions in Africa and Asia on malaria control and NTD eradication.